ProQR Therapeutics NV. Daily Stock Analysis

Daily Stock Analysis, PRQR, ProQR Therapeutics NV, priceseries

ProQR Therapeutics NV. Daily Stock Analysis
Stock Information
Open
0.91
Close
0.93
High
0.95
Low
0.90
Previous Close
0.90
Daily Price Gain
0.03
YTD High
8.60
YTD High Date
Jan 4, 2022
YTD Low
0.89
YTD Low Date
Mar 4, 2022
YTD Price Change
-7.15
YTD Gain
-88.49%
52 Week High
9.46
52 Week High Date
Mar 25, 2021
52 Week Low
0.89
52 Week Low Date
Mar 4, 2022
52 Week Price Change
-3.54
52 Week Gain
-79.19%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 2. 2017
4.15
Mar 16. 2017
4.53
10 Trading Days
9.09%
Link
LONG
Mar 27. 2017
4.60
Apr 12. 2017
4.85
12 Trading Days
5.38%
Link
LONG
Apr 27. 2017
4.90
May 12. 2017
5.16
11 Trading Days
5.27%
Link
LONG
Sep 22. 2017
6.20
Sep 26. 2017
6.51
2 Trading Days
5.08%
Link
LONG
Feb 13. 2018
3.12
Feb 28. 2018
3.38
10 Trading Days
8.04%
Link
LONG
Apr 10. 2018
3.10
Apr 24. 2018
3.38
10 Trading Days
9.04%
Link
LONG
May 3. 2018
4.05
May 30. 2018
5.36
18 Trading Days
32.45%
Link
LONG
May 31. 2018
5.70
Jun 18. 2018
6.56
12 Trading Days
15.00%
Link
LONG
Aug 31. 2018
7.65
Sep 25. 2018
19.40
16 Trading Days
153.63%
Link
LONG
Oct 31. 2018
18.20
Nov 7. 2018
20.22
5 Trading Days
11.11%
Link
LONG
Oct 9. 2019
6.21
Oct 10. 2019
6.55
1 Trading Days
5.52%
Link
LONG
Oct 16. 2019
6.34
Oct 28. 2019
7.11
8 Trading Days
12.08%
Link
LONG
Dec 6. 2019
8.31
Dec 20. 2019
9.02
10 Trading Days
8.50%
Link
LONG
Jun 17. 2020
5.71
Jun 26. 2020
6.17
7 Trading Days
8.05%
Link
LONG
Mar 9. 2021
4.72
Mar 31. 2021
6.51
16 Trading Days
37.99%
Link
LONG
Aug 2. 2021
5.50
Aug 16. 2021
5.99
10 Trading Days
8.99%
Link
LONG
Aug 23. 2021
6.16
Sep 20. 2021
7.86
19 Trading Days
27.59%
Link
LONG
Sep 28. 2021
8.10
Sep 29. 2021
8.59
1 Trading Days
6.11%
Link
Company Information
Stock Symbol
PRQR
Exchange
NasdaqGM
Company URL
http://www.proqr.com
Company Phone
31(0)88 166 7000
CEO
Daniel Anton de Boer
Headquarters
-
Business Address
DARWINWEG 24, LEIDEN, NETHERLANDS 2333CR
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001612940
About

ProQR Therapeutics NV operates as a biopharmaceutical company, which engages in the discovery and development of Ribonucleic Acid RNA based therapeutics for the treatment of genetic disorders. Its initial focus is on the development of a disease-modifying therapy for the treatment of cystic fibrosis (CF). The company was founded by Daniel de Boer, Gerard Platenburg, Henri Termeer and Dinko Valerio on February 21, 2012 and is headquartered in Leiden, the Netherlands.

Description

ProQR Therapeutics N.V., a biopharmaceutical company, engages in the discovery and development of RNA-based therapeutics for the treatment of genetic disorders. The company's clinical stage candidates include QR-010, a RNA-based oligonucleotide that is in Phase Ib clinical trial for the treatment of cystic fibrosis. It also develops QR-110, which is in pre-clinical development stage for the treatment of Leber's congenital amaurosis. The company was founded in 2012 and is headquartered in Leiden, the Netherlands.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading